TherapeuticsMD (TXMD) Interest Coverage Ratio (2010 - 2025)
TherapeuticsMD (TXMD) reported Interest Coverage Ratio of 287.33 for Q3 2025, up 23.99% on a YoY basis from 231.75 in Q3 2024, and up 17.31% quarter-over-quarter from 347.5 in Q2 2025.
TherapeuticsMD (TXMD) Interest Coverage Ratio (2010 - 2025) Analysis & Trends
TherapeuticsMD has reported Interest Coverage Ratio for 12 years, with the latest figure at 287.33 in Q3 2025.
- For the quarter ending Q3 2025, Interest Coverage Ratio rose 23.99% year-over-year to 287.33; the trailing twelve-month figure through Mar 2026 stood at 766.4 (down 30.87% YoY), and the FY2021 full-year result was 3.53, up 40.95% from the prior year.
- Interest Coverage Ratio for Q3 2025 stood at 287.33, up from 347.5 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 1.24 in Q1 2022, with the low at 640.5 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 186.98 across 5 years, with a median of 54.93 in 2023.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio surged 64.8% — and 2023, when it plunged 4200.62%.
- TherapeuticsMD's Interest Coverage Ratio stood at 6.56 in 2021, then soared by 81.1% to 1.24 in 2022, then tumbled by 7047.55% to 88.65 in 2023, then plunged by 326.4% to 378.0 in 2024, then grew by 23.99% to 287.33 in 2025.
- The last three Interest Coverage Ratio figures came in at 287.33 (Q3 2025), 347.5 (Q2 2025), and 640.5 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -287.33 |
| Jun 30, 2025 | -347.50 |
| Mar 31, 2025 | -640.50 |
| Sep 30, 2024 | -378.00 |
| Jun 30, 2024 | -557.80 |
| Sep 30, 2023 | -88.65 |
| Jun 30, 2023 | -54.93 |
| Mar 31, 2023 | -53.34 |
| Mar 31, 2022 | -1.24 |
| Dec 31, 2021 | -6.56 |
| Sep 30, 2021 | -7.41 |
| Jun 30, 2021 | -4.63 |
| Mar 31, 2021 | -2.86 |
| Dec 31, 2020 | -6.81 |
| Sep 30, 2020 | -3.71 |
| Jun 30, 2020 | -6.41 |
| Mar 31, 2020 | -8.13 |
| Dec 31, 2019 | -7.84 |
| Sep 30, 2019 | -4.84 |
| Jun 30, 2019 | -10.34 |